Premium
Managing the high cost of newer oral agents in type 2 diabetes
Author(s) -
Gadsby Roger,
Patel Vinod,
Riley Andrew
Publication year - 2010
Publication title -
prescriber
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.106
H-Index - 3
eISSN - 1931-2253
pISSN - 0959-6682
DOI - 10.1002/psb.659
Subject(s) - medicine , nice , type 2 diabetes , intensive care medicine , risk analysis (engineering) , diabetes mellitus , computer science , endocrinology , programming language
Over recent years there has been a significant number of new drugs launched for the management of diabetes. While this is good news for patients with the condition it has the potential to put significant pressure on the drugs bill. In this Expert Panel Discussion the participants discuss the rising cost of diabetes management and the impact of new drugs. In particular they discuss the NICE estimates for the cost of implementation of recent guidance on use of new drugs and how this guidance can be implemented most cost‐effectively.